|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-4-17
|
|
pubmed:abstractText |
Gene expression analysis identifies several breast cancer subtypes. We examined the relationship of neoadjuvant chemotherapy response to outcome among these breast cancer subtypes.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2329-34
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17438091-Adult,
pubmed-meshheading:17438091-Aged,
pubmed-meshheading:17438091-Antineoplastic Agents,
pubmed-meshheading:17438091-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17438091-Breast Neoplasms,
pubmed-meshheading:17438091-Female,
pubmed-meshheading:17438091-Humans,
pubmed-meshheading:17438091-Immunohistochemistry,
pubmed-meshheading:17438091-Middle Aged,
pubmed-meshheading:17438091-Neoplasm Staging,
pubmed-meshheading:17438091-Receptor, erbB-2,
pubmed-meshheading:17438091-Receptors, Estrogen,
pubmed-meshheading:17438091-Receptors, Progesterone,
pubmed-meshheading:17438091-Survival Analysis
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
|
|
pubmed:affiliation |
Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7305, USA. Lisa_Carey@med.unc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
